ImmunoReagents

Executive Summary

ImmunoReagents is a US-based manufacturer of high-quality polyclonal antibodies and immunoassay reagents serving the life science research and in-vitro diagnostics (IVD) markets. Founded in 1999 and headquartered in Raleigh, North Carolina, the company produces primary and secondary antibodies, purification tools, and bulk reagents under cGMP and QSR compliant procedures. Its products are widely used in ELISA, western blot, immunohistochemistry, and flow cytometry. With over two decades of operational history, ImmunoReagents has built a reputation for consistent quality and reliability, supplying both academic researchers and diagnostic manufacturers.

Upcoming Catalysts (preview)

• Q4 2026Expansion of cGMP manufacturing capacity to meet growing IVD demand80% success
• Q1 2027Launch of new recombinant antibody product line targeting emerging biomarkers60% success
• Q3 2026Strategic distribution partnership for Asia-Pacific market entry70% success